Annual report pursuant to Section 13 and 15(d)

Revision (Details)

v3.20.1
Revision (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2019
Sep. 30, 2019
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Accumulated deficit $ (25,431,084) $ (25,431,084) $ (29,361,937) $ (11,291,776)  
Accumulated other comprehensive loss - foreign currency translation adjustment (297,571) (297,571) (257,747) (236,860)  
Total Avalon GloboCare Corp. stockholders' equity and non-controlling interest 5,746,812 5,746,812 4,465,073 12,116,203  
Non-controlling interest (862,200) $ (585,394)
Loss from noncontrolling interest deficit adjustment (1,042,210) (862,200) (862,200)  
Total Other Income (Expense), net 100,079 145,402 1,307,069 (421,161)  
LOSS BEFORE INCOME TAXES (5,376,268) (14,140,010) (18,070,161) (8,052,296)  
NET LOSS (5,376,268) (14,140,010) (18,070,161) (8,052,296)  
NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST (278,174)  
NET LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS $ (5,376,268) $ (14,140,010) $ (18,070,161) $ (7,774,122)  
NET LOSS PER COMMON SHARE ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS:          
Basic and diluted $ (0.07) $ (0.19) $ (0.24) $ (0.11)  
As Reported [Member]          
Accumulated deficit $ (23,913,011) $ (23,913,011)      
Accumulated other comprehensive loss - foreign currency translation adjustment (302,023) (302,023)      
Total Avalon GloboCare Corp. stockholders' equity and non-controlling interest 7,260,433 7,260,433      
Non-controlling interest (1,513,621) (1,513,621)      
Total Other Income (Expense), net 1,142,289 1,007,602      
LOSS BEFORE INCOME TAXES (4,334,058) (13,277,810)      
NET LOSS (4,334,058) (13,277,810)      
NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST (475,863) (656,575)      
NET LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS $ (3,858,195) $ (12,621,235)      
NET LOSS PER COMMON SHARE ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS:          
Basic and diluted $ (0.05) $ (0.17)